Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabota for nocturnal calf cramps in lumbar spinal stenosis
NCT02444351Completed
- Sponsor
- Yonsei University
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in nocturnal leg cramps (NLC), sponsored by Yonsei University. Primary endpoint: Pain score at 2 weeks. Started Jun 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
nocturnal leg cramps (NLC)
Beyond the preview
Go deeper on NCT02444351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444351.